Prospective, Single-Center, Phase II Study to Standardize the Mitotane Dosing Regimen in Combination with Platinum-Based Chemotherapy in the First-Line Treatment for Adrenocortical Cancer. Voprosy onkologii, v. 72, n. 1, p. OF-2404, 11 Mar.2026.